Lexaria Bioscience (LEXX) Common Equity (2010 - 2026)
Lexaria Bioscience (LEXX) reported Common Equity of $4.74 million for fiscal Q3 2026 (quarter ended May 31, 2026), down 8.3% from $5.17 million a year earlier and down 23.7% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience posted Common Equity of $2.99 million, down 61.0% from FY2024.
- Common Equity has a five-year compound annual growth rate of 3.8% (FY2020 to FY2025).
- By fiscal year, Common Equity came in at $7.66 million in FY2024 (+185.8%), $2.68 million in FY2023 (-64.9%), $7.63 million in FY2022 (-41.6%) and $13.06 million in FY2021 (+426.3%).
- Five-year quarterly Common Equity spans a low of $2.68 million in fiscal Q4 2023 and a high of $13.06 million in fiscal Q4 2021.
- Year over year, Common Equity has now declined in each of the last five quarters, with growth averaging 24.8% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was fiscal Q1 2022 (growth of 529.8%); the low point was fiscal Q4 2023 (a decline of 64.9%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $6.21 million (Q2 2026), $4.52 million (Q1 2026) and $2.99 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Lexaria Bioscience | 3.39 Mn | -12.26 Mn | - | 4.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 4.74 Mn |
| Feb 28, 2026 | 6.21 Mn |
| Nov 30, 2025 | 4.52 Mn |
| Aug 31, 2025 | 2.99 Mn |
| May 31, 2025 | 5.17 Mn |
| Feb 28, 2025 | 6.76 Mn |
| Nov 30, 2024 | 9.39 Mn |
| Aug 31, 2024 | 7.66 Mn |
| May 31, 2024 | 9.75 Mn |
| Feb 29, 2024 | 6.15 Mn |
| Nov 30, 2023 | 3.37 Mn |
| Aug 31, 2023 | 2.68 Mn |
| May 31, 2023 | 5.24 Mn |
| Feb 28, 2023 | 4.63 Mn |
| Nov 30, 2022 | 5.93 Mn |
| Aug 31, 2022 | 7.63 Mn |
| May 31, 2022 | 8.91 Mn |
| Feb 28, 2022 | 11.22 Mn |
| Nov 30, 2021 | 11.47 Mn |
| Aug 31, 2021 | 13.06 Mn |
API Access
Lexaria Bioscience Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();